Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Helping patients to be heard: What the new NICE guidance means for people with tinnitus

      Imagine you’re trying to enjoy a moment of silence, but it’s interrupted by a relentless ringing noise. What if this happened all day, every day? That’s persistent tinnitus, and as an audiologist, I see the impact of this condition every day.

      By: Vai Maheswaran | 11 March 2020
      At least 10% of adults in the UK suffer from persistent tinnitus , and over the next decade this is only set to increase ! Despite these numbers, tinnitus and other types of hearing loss are often overlooked as the serious health conditions they are. This is largely due to a general lack of understanding around the subject, particularly among GPs, who are the first point of contact for patients . This means that often, those who are affected by tinnitus are left feeling unsure of how to manage their condition, which can then become a vicious cycle as people end up back in their GP’s surgery for guidance.

      As healthcare professionals we need to be aware of the significant impact tinnitus can have on an individual’s health and wellbeing, such as their mental health, relationships with family and friends, and their ability to sleep, concentrate and work. Therefore, it is essential that those affected are reassured, offered information and given prompt treatment such as hearing aids or cognitive behavioural therapy.

      With this in mind, the new tinnitus guideline by NICE is a fantastic starting point in ensuring a standardised care pathway is put in place for those affected by tinnitus in England.

      In addition to assessment advice, the guideline highlights the importance of further research into developing and investigating treatments for the condition, which is vital in ensuring the needs of all groups of patients are met.

      I have high hopes that publishing the guidance will be a positive step forward in the way tinnitus is approached, managed and treated by health professionals, making a difference in the lives of so many.

      Recent Posts

      Could ‘chemical earmuffs’ prevent noise-induced hearing damage?

      Researchers in the US have identified molecules in the inner ear that are involved in the damage that loud noise causes to hearing. Blocking their activity protected against this damage when mice were exposed to loud noise. These findings could form the basis of new treatments to protect people’s hearing from noise.

      By: Tracey Pollard
      16 March 2020

      A clinical trial of a new investigational drug for vertigo in Ménière’s disease - OTO-104

      A clinical study team are looking for volunteers to test their new investigational drug, OTO-104, for vertigo episodes in Ménière’s disease.

      By: The OTO-104 Study Team
      11 March 2020

      Our future research leaders

      Last month, we invited our PhD students and our early-career Fellows to visit our head office in Highbury, to find out more about the work we do, to meet each other and to meet our staff. Marta Narkiewicz, from our research team, tells us more about the day.

      By: Marta Narkiewicz
      10 March 2020

      Interview with the Information Line

      Vicky Thurston works for the Information Line here at Action on Hearing Loss. After starting at the charity as a six week temp, she has now worked here for the last 6 years. In this blog post, Vicky tells us how all about the information line and how important it can be to those calling in.

      By: Vicky Thurston
      25 February 2020

      Recent Posts

      Could ‘chemical earmuffs’ prevent noise-induced hearing damage?

      Researchers in the US have identified molecules in the inner ear that are involved in the damage that loud noise causes to hearing. Blocking their activity protected against this damage when mice were exposed to loud noise. These findings could form the basis of new treatments to protect people’s hearing from noise.

      By: Tracey Pollard
      16 March 2020

      A clinical trial of a new investigational drug for vertigo in Ménière’s disease - OTO-104

      A clinical study team are looking for volunteers to test their new investigational drug, OTO-104, for vertigo episodes in Ménière’s disease.

      By: The OTO-104 Study Team
      11 March 2020

      Our future research leaders

      Last month, we invited our PhD students and our early-career Fellows to visit our head office in Highbury, to find out more about the work we do, to meet each other and to meet our staff. Marta Narkiewicz, from our research team, tells us more about the day.

      By: Marta Narkiewicz
      10 March 2020

      Interview with the Information Line

      Vicky Thurston works for the Information Line here at Action on Hearing Loss. After starting at the charity as a six week temp, she has now worked here for the last 6 years. In this blog post, Vicky tells us how all about the information line and how important it can be to those calling in.

      By: Vicky Thurston
      25 February 2020

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.